COLD vs GILD · rev $2.67B vs P/E 18, rev $29.44B
Americold Realty Trust (COLD) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Americold Realty Trust (COLD) is a reit - industrial company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported COLD revenue for 2024-12-31 was $2.67B. Net income was -$94.7M. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. COLD currently screens at market cap $4.75B.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
COLD currently screens at market cap $4.75B. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the COLD and GILD stock pages for the full models.
Not investment advice.